EDGE
SIGN4L, a dynamic provider of agile and adaptive electronic warfare and intelligence (EW&I) solutions, today launched two state-of-the-art solutions that are set to offer a tactical advantage in the missions of tomorrow. V-Protect, a radio frequency (RF) communication jamming system, and NavControl-G, a specialised counter-drone capability, are well positioned to become game-changers in shaping favourable outcomes in an increasingly digitalised defence landscape.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210221005031/en/
The solutions were unveiled at the EDGE pavilion at the ongoing International Defence Exhibition and Conference (IDEX 2021) that runs until 25 February at the Abu Dhabi National Exhibition Centre (ADNEC).
V-Protect is an advanced mobile active and reactive high-power jammer system aimed at helping block common terrestrial RF signal technologies as well as portable satcom equipment, spanning radio, walkie-talkie, mobile and Wi-Fi frequencies. Boasting a counter-improvised explosive device (C-IED) and counter-drone measures, the user-friendly model is to be installed in a standard SUV and offers automatic operability by utilizing 16 channels and high emitting power amplifiers to provide support in enhancing protection range and combatting various threats across the frequency domain.
NavControl-G is a sophisticated transmitter unit designed to help prevent unmanned aerial vehicles (UAVs) from trespassing into specific locations. To help safeguard a sensitive area, the system can emulate GPS signals to generate position and timing inaccuracies, thereby taking control of non-cooperating unmanned vehicles. Encased in a shock-proof container, the system can be seamlessly integrated across multiple configurations - either in fixed locations or deployed on the field when required.
Waleid Al Mesmari, Vice President of Program Management for the Electronic Warfare & Intelligence cluster at EDGE, said: “Electronic warfare and intelligence make up the backbone of modern defence and security systems. SIGN4L is at the frontlines in pioneering breakthrough technologies that help our clients expand their options in a rapidly changing world. By assisting our clients with the management of their complex security and performance requirements, our latest solutions are prime examples of our agile offerings at work that focus energy to obscure, neutralise and attack adversaries.”
SIGN4L brings a startup ethos to designing and producing state-of-art open-architecture digital and RF-based security products and services for governments and businesses in the region. The company has implemented a rigorous cycle of threat analysis, research, and development to monitor, analyse and counter emerging risks. SIGN4L is part of the Electronic Warfare & Intelligence cluster at EDGE, an advanced technology group that ranks among the top 25 military suppliers in the world.
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20210221005031/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Volante Technologies Customers Successfully Navigate Critical Regulatory Deadlines for EU SEPA Instant and Global SWIFT Cross-Border Payments16.12.2025 10:00:00 CET | Press release
PaaS leader ensures seamless migrations and uninterrupted payment operations Volante Technologies, the global leader in Payments as a Service (PaaS), today announced it has successfully upgraded its clients to meet the latest SEPA Instant Payments Regulation (IPR) and SWIFT SRG 2025 mandate, which came into effect October 9th and November 22nd, 2025, respectively. This announcement follows the major FedISO upgrade in July, which shifted trillions of dollars in payments to the new ISO 20022 messaging format. SEPA IPR is a significant European milestone, requiring payments to be made within 10 seconds and at any time of day, throughout the year. Adoption was mandatory and Eurozone banks were compelled to meet strict deadlines, with January 9th, 2025 the deadline for receiving incoming instant payments and October 9th the deadline for sending outgoing instant payments. The latest deadline impacted more than 700 banks across Europe, with non-compliance penalties reaching at least 10% of an
TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth16.12.2025 09:05:00 CET | Press release
TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through their proprietary cell technology, C-Stem™ is delighted to announce the appointment of skilled biotech leader, Mark Rothera, as Chief Executive Officer and Board member. He succeeds Frédéric Desdouits, who is stepping down after five years in the role. In the new leadership configuration, co-founders Kévin Alessandri and Maxime Feyeux will transition from daily operations to focus on their roles on the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215145193/en/ Mark Rothera, CEO TreeFrog Therapeutics Elsy Boglioli, Chair of the Board of TreeFrog Therapeutics, commented “On behalf of the Board, we are delighted to welcome Mark to TreeFrog. His 30+ years of biopharma leadership, including most recently, three biotech CEO roles in gene therapy and biologics, will be invaluable as we advance our Parkinson’s and liver
RoslinCT and Ayrmid Ltd. Announce Expansion of Strategic Partnership to Manufacture Omisirge® (omidubicel-onlv) for Second FDA-Approved Indication in Severe Aplastic Anemia (SAA)16.12.2025 09:00:00 CET | Press release
RoslinCT is performing technology transfer and will support commercial manufacture of Omisirge® for an additional indication following successful clinical trialsOmisirge® now FDA-approved for an expanded patient population in hematologyRoslinCT continues to support and advance multiple cell therapy projects at its Hopkinton, MA facility Ayrmid Ltd., the parent company of Gamida Cell Inc., a pioneering cell therapy company transforming cells into powerful therapeutics, and RoslinCT, a global leader in cell and gene therapy contract development and manufacturing, today announced the expansion of their strategic partnership to include the execution of a commercial supply agreement to support production of Omisirge® (omidubicel-onlv). Following positive clinical trial results, Omisirge® has received FDA approval for a second indication, broadening its use in the treatment of hematology patients. Under the commercial supply agreement, RoslinCT will complete technology transfer and support c
Echoworx Secures FSQS-Netherlands Certification, Strengthening Trust in Financial Data Protection16.12.2025 07:00:00 CET | Press release
Leading encryption provider deepens commitment to European financial sector with rigorous new supplier qualification, building on existing UK & Ireland certification. Echoworx, a global leader in email and data encryption, proudly announces it has achieved Financial Services Qualification System (FSQS) registered supplier status for the Netherlands. This certification powerfully demonstrates Echoworx’s commitment to the highest standards of security and compliance. This achievement expands on the company’s existing FSQS certification for the UK and Ireland, secured in 2020. By successfully completing the rigorous qualification for the Netherlands, Echoworx reinforces its alignment with the stringent demands of the European financial market. The FSQS system, managed by Hellios, provides a single, reliable standard for vetting third-party suppliers, streamlining procurement for major banks and financial institutions. Think of FSQS as a high-security passport for technology partners. It p
Nippon Electric Glass to Start World’s First Mass Production of Low-Carbon Pharmaceutical Glass Tubing Using an All-Electric Furnace16.12.2025 03:00:00 CET | Press release
Nippon Electric Glass Co., Ltd. (NEG)(TOKYO:5214), a global leader in specialty glass headquartered in Otsu, Japan, announced it will begin the world’s first mass production of pharmaceutical-grade glass tubing using an all-electric melting furnace. Commercial production is scheduled to start in December 2025 at its subsidiary in Selangor, Malaysia. This breakthrough introduces a new manufacturing model for pharmaceutical packaging. By combining NEG’s proprietary all-electric melting technology with renewable energy, CO2 emissions from glass tubing production can be reduced by up to 90%*1 compared with conventional fossil-fuel combustion furnaces. This positions NEG as a major supplier capable of delivering both high-performance borosilicate glass and a significantly lower carbon footprint, directly addressing global sustainability demands from pharmaceutical companies and regulators. NEG is a leading global supplier of arsenic-free, environmentally friendly borosilicate glass tubing f
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom